• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 1159

Bacillus coagulans strain BCP92 spore preparation

Intended Use: Intended for use as an ingredient at a maximum level of 2 x 109 colony forming units (CFU)/serving in baked goods and baking mixes; breakfast cereals; non-alcoholic beverages and beverages bases; coffee and tea; milk and milk products; dairy product alternative; fruit juices; condiments and relishes; confections and frostings; frozen dairy desserts and mixes; fruit and water ices; jams and jellies; gelatins, puddings and fillings; alcoholic beverages; grain products and pastas; hard candy; soft candy; chewing gum; extracts, flavorings, herbs, seeds, spices, seasonings, and blends; nuts and nut products; plant protein products; processed fruits; processed vegetables and vegetable juices; snack foods; soups and soup mixes; sugar; and sweet sauces, toppings, and syrups.
Basis: Scientific procedures
Notifier: Pellucid Lifesciences Pvt., Limited
Notifier Address: Plot No. 3538, Phase 4, GIDC Industrial Estate
Chhatral 382729, Gandhinagar, Gujarat
FDA's Letter: Pending